Compliance For ‘Gluten Free’ Claims For Fermented, Hydrolyzed Supplements Relies On Recordkeeping
Without Reliable Testing, US FDA Will Ask For ‘Information That Provides Adequate Assurance’
Final rule amends FDA regulation on gluten-free labeling to provide alternative means for the agency to verify compliance. It will determine whether a firm is compliant from records it must maintain, and make available for inspection and copying, of the fermented or hydrolyzed supplements and food products bearing the claim.
You may also be interested in...
FDA’s final rule updating Nutrition Facts labels will have a far-reaching impact on products beyond labeling. The requirements also will change nutrient daily values, potentially affecting product claims and the way in which consumers perceive products, say food consultants during an FDLI webinar.
HHS' latest semi-annual regulatory agenda lists a US-Canada Regulatory Cooperation Council pilot program as the source of a proposed rule to add the common cold indication for monograph OTC antihistamine ingredients that FDA plans to introduce in March 2016.
Food products with "gluten-free" claims will be misbranded if they do not meet the conditions of a proposed rule FDA published in the Jan. 23 Federal Register